Acrivon Therapeutics Inc.... (ACRV)

AI Score

Unlock

2.00

-0.03 (-1.48%)

At close: Apr 23, 2025, 3:59 PM

2.01

0.75%

Pre-market: Apr 24, 2025, 09:26 AM EDT

Acrivon Therapeutics Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q4 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Dec 31, 2021
Cash & Equivalents	39.82M	43.41M	46.01M	24.61M	36.02M	29.86M	38.07M	27.49M	29.52M	32.08M	83.86M	99.6M
Short-Term Investments	139.66M	144.04M	134.53M	85.37M	91.44M	112.23M	112.88M	92.72M	98.23M	44.74M	n/a	n/a
Long-Term Investments	5.09M	15.39M	40.32M	417K	414K	411K	408K	39.27M	41.88M	388K	n/a	n/a
Other Long-Term Assets	1.84M	1.84M	468K	348K	251K	n/a	n/a	388K	4.73M	1.54M	612K	388K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.15M	1.53M	1.82M	2.17M	2.23M	2.4M	2.33M	3.75M	4.34M	n/a	n/a	n/a
Total Current Assets	181.63M	188.98M	182.36M	112.14M	129.69M	144.49M	153.28M	123.96M	127.75M	78.67M	87.16M	100.41M
Property-Plant & Equipment	8.03M	8.47M	7.44M	7.61M	7.91M	6.19M	6.36M	6.57M	6.86M	7.11M	7.22M	5.79M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	14.96M	25.7M	48.23M	8.38M	8.57M	6.6M	6.77M	46.23M	53.48M	9.04M	7.83M	6.18M
Total Assets	196.59M	214.68M	230.59M	120.52M	138.26M	151.09M	160.05M	170.2M	181.23M	87.71M	95M	106.59M
Account Payables	758K	1.51M	1.26M	2.06M	5.05M	1.5M	1.27M	1.37M	904K	1.98M	1.9M	964K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	69K	n/a	n/a	66K
Short-Term Debt	n/a	n/a	978K	n/a	877K	776K	753K	740K	n/a	n/a	n/a	n/a
Other Current Liabilities	5.46M	12.27M	5.12M	4.13M	2.98M	3.24M	2.18M	1.42M	2.15M	2.4M	881K	667K
Total Current Liabilities	17.21M	14.82M	11.28M	9.04M	13.3M	9.3M	7.02M	5.68M	6.52M	6.39M	4.45M	2.91M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	-1	n/a	n/a	n/a	n/a	n/a	122.52M	122.52M	122.52M
Total Long-Term Liabilities	2.59M	2.97M	3.24M	3.5M	3.77M	3.64M	3.85M	4.05M	4.24M	126.94M	127.12M	127.48M
Total Liabilities	19.8M	17.79M	14.53M	12.54M	17.07M	12.94M	10.87M	9.73M	10.75M	133.33M	131.57M	130.4M
Total Debt	3.65M	4.01M	4.22M	4.45M	4.64M	4.42M	4.6M	4.79M	4.96M	5.14M	5.31M	5.63M
Common Stock	31K	31K	31K	23K	23K	22K	22K	22K	22K	2K	2K	2K
Retained Earnings	-196.98M	-174.15M	-151.7M	-132.91M	-116.42M	-97.17M	-82.7M	-68.79M	-56.03M	-47.1M	-37.91M	-24.86M
Comprehensive Income	447K	782K	-19K	-70K	-83K	-302K	-427K	9K	-95K	-133K	n/a	n/a
Shareholders Equity	176.79M	196.89M	216.06M	107.98M	121.19M	138.15M	149.18M	160.47M	170.47M	-45.62M	-36.58M	-23.81M
Total Investments	144.75M	159.43M	174.85M	85.78M	91.86M	112.23M	112.88M	132M	140.11M	44.74M	n/a	n/a